Related Experiment Video

Updated: May 25, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Metabolic syndrome and its components associated with endothelial dysfunction in chronic kidney disease patients

Qiong Bai1, Xuan Lai, Ai-Hua Zhang

  • 1Division of Nephrology, Peking University Third Hospital, Beijing, People's Republic of China.

Vascular Health and Risk Management
|January 25, 2012
PubMed

Insights

Metabolic syndrome (MetS) and its components, like high blood glucose, are linked to poorer endothelial function in chronic kidney disease (CKD) patients, impacting cardiovascular health.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Cardiovascular disease (CVD) prevalence is elevated in chronic kidney disease (CKD) patients.
  • Endothelial dysfunction is a key early indicator of cardiovascular events.

Purpose of the Study:

  • To investigate the relationship between metabolic syndrome (MetS) components and endothelial cell function in CKD patients.
  • To assess endothelial function using flow-mediated dilatation (FMD) in relation to MetS.

Main Methods:

  • Cross-sectional study of 161 CKD patients (stages 1-5).
  • Endothelial function assessed via brachial artery flow-mediated dilatation (FMD).
  • Metabolic syndrome defined by National Cholesterol Education Program-Adult Treatment Panel III criteria.

Main Results:

  • Flow-mediated dilatation (FMD) was significantly lower in CKD patients with MetS compared to those without.
  • FMD showed a negative correlation with waist circumference in women and fasting blood glucose.
  • Fasting blood glucose emerged as an independent factor associated with reduced FMD.

Conclusions:

  • Metabolic syndrome is closely associated with diminished endothelial function in CKD.
  • Specific MetS components, including waist circumference (women) and fasting blood glucose, correlate with decreased FMD.
  • Findings highlight the impact of MetS on vascular health in CKD patients.
Abstract

Keywords:
chronic kidney diseaseendothelial dysfunctionflow-mediated dilatationmetabolic syndrome

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...